The GLP-1 drugs, which include semaglutide (Ozempic, Rybelsus, Wegovy) and tirzepatide (Mounjaro, Zepbound), are turning out to have effects that go beyond shedding pounds and controlling diabetes. For one, they may allow people with knee osteoarthritis to avoid or delay knee replacement surgery. This was the finding of a study published online June 2, 2026, by Regional Anesthesia & Pain Medicine. Previous studies have found that the use of these drugs may help relieve knee pain caused […]

Kendra Wilkinson has dropped over two dress sizes since taking a GLP-1. The former “Girls Next Door” star took to her Instagram Stories to share she “lost so much weight” and is fitting into her old jeans again. When asked about the secret to her weight loss, she shared with her followers that her results are due to the use of an unnamed GLP-1, which she teased an upcoming ad for. Kendra Wilkinson has dropped over two dress […]

Weight loss drugs like semaglutide and tirzepatide have transformed the management of obesity and Type 2 diabetes and in the process lowered risk of metabolic diseases. But research has shown that the medication works best only when paired with the right diet. Because these drugs suppress appetite and reduce food intake, patients who do not follow a structured nutrition plan may inadvertently lose muscle along with fat, develop vitamin and mineral deficiencies, and struggle to maintain their […]

Amgen (AMGN -0.87%) is betting that the convenience of its weight loss treatment will make it a winner, and it might be right. Its candidate MariTide is a monthly injection that aims to directly challenge the anti-obesity drugs made by Eli Lilly (LLY -0.27%) and Novo Nordisk (NVO +1.49%), which in their original formulations are administered by a weekly injection. If the program’s phase 3 clinical trial data look good, Amgen could enter the market and become […]

With prescription weight loss medicines being advertised illegally on social media alongside quick-fix slimming claims, the Medicines and Healthcare products Regulatory Agency (MHRA), is warning Brits to not let summer slimming put their health at risk.  From over-dosing on prescription weight-loss meds to buying dangerous fakes online, the MHRA reveals the mistakes that could leave you seriously ill, and the simple steps to lose weight safely.  1. Follow doctor’s orders if you are prescribed a GLP-1  If you’ve been prescribed a GLP-1 weight-loss medicine, don’t be tempted to fast-track your […]

Eli Lilly (LLY -0.30%) brought in $19.8 billion in revenue in the first quarter of 2026, and most of it can be traced back to the medicines everyone has heard of by now: tirzepatide, sold as Mounjaro for type 2 diabetes and Zepbound for obesity. Its weight loss medicines, and the ones behind them in the pipeline, will likely carry the top line for years, though leadership in that market is never guaranteed. But that didn’t stop […]

Novo Nordisk shareholders are suing the drugmaker over its experimental obesity treatment CagriSema, alleging the company misled investors about a key clinical trial before releasing disappointing results that wiped billions of dollars off its market value. A federal judge on Tuesday allowed parts of that lawsuit to move forward, finding that investors had plausibly alleged that some statements about CagriSema’s tolerability and the design of the late-stage trial may have been misleading. The ruling does not determine […]

Kendra Wilkinson “couldn’t feel more amazing” about her bikini body as she continues her GLP-1 journey. On Tuesday, the former Playboy model shared a sponsored video with Effecty, the weight loss drug she’s been using. “Hey guys. I am three months in on my GLP-1 journey with Effecty and I couldn’t feel more amazing and more confident in my body,” she gushed. Kendra Wilkinson “couldn’t feel more amazing” about her bikini body as she continues her GLP-1 […]

Novo Nordisk sued rival Eli Lilly in a U.S. federal court on July 21, accusing the U.S. drugmaker of false advertising in claiming its weight-loss medicines outperform Novo’s drugs. The Danish company filed the lawsuit in U.S. District Court in New Jersey, alleging Lilly violated federal and state false advertising and unfair competition laws, including the Lanham Act, through nationwide advertising campaigns for obesity drug Zepbound and diabetes treatment Mounjaro. Novo alleges Lilly compared the highest approved […]